Haemostatic Wound Healing Sheet

Introduction

It is a cost effective, biocompatible as well as biodegradable chemically modified fibrin sheet which is prepared by graft copolymerising the firbin film, obtained by during the purified, bleached and masticated fibrin paste with a biocompatible, hydrophilic monomer, followed by optional incorporation of drug and subsequent drying and casting into sheet of desired size and shape. The sheet has potential use as a dressing aid in the treatment of various wounds of diversified nature including external injury, cut, burn and even ulcers in animal as well as human being. It prevents loss of electrolyte from the wound site and also prevents any infection in the wound. The uniqueness of the process lies in the economical utilisation of crude fibrin, which is otherwise thrown as waste, thereby making wealth out of waste.

Industry classification

Primary : Slaughter house / animal byproducts
Secondary : Drug / pharmaceutical industry

Product type : Commercial

Manufacturing

a) process used
Primary : Biochemical processing
Secondary : Sheet Casting

b) Major machinery used : Blender, drier

Status : Yet to be Licensed

Economic Information:

Minimum Economic size: 1000 sheets of 100 cm2 per day
Optimum Investment : Rs.10 lakhs

Major Raw Materials Required :

Crude fibrin

Patent Information

If Patented : Indian patent applied for
Patent No. : Appl. No.2450DEL97
Country : India
Date granted : Patent Pending

Contact for more information:

Dr. T. Ramasami,
Director, Central Leather Research Institute (CLRI),
Chennai -600 020, India
Tel: +91-(0)44-4910846
Fax: +91-(0)44-4912150
Email: clrimd@md2.vsnl.net.in